Tasosartan
CAS No. 145733-36-4
Tasosartan ( WAY-ANA 756 )
Catalog No. M21071 CAS No. 145733-36-4
Tasosartan is an antagonist of angiotensin II type 2 (AT2) receptor (IC50 = 1.2 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 67 | Get Quote |
|
5MG | 110 | Get Quote |
|
10MG | 177 | Get Quote |
|
25MG | 300 | Get Quote |
|
50MG | 447 | Get Quote |
|
100MG | 624 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTasosartan
-
NoteResearch use only not for human use.
-
Brief DescriptionTasosartan is an antagonist of angiotensin II type 2 (AT2) receptor (IC50 = 1.2 nM).
-
DescriptionTasosartan is an antagonist of angiotensin II type 2 (AT2) receptor (IC50 = 1.2 nM).
-
SynonymsWAY-ANA 756
-
PathwayEndocrinology/Hormones
-
TargetRAAS
-
RecptorAT2 receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number145733-36-4
-
Formula Weight411.46
-
Molecular FormulaC23H21N7O
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL (303.80 mM)
-
SMILESCc1nc(C)c2c(n1)N(Cc1ccc(-c3ccccc3-c3nn[nH]n3)cc1)C(=O)CC2
-
Chemical Name8-((2'-(1H-tetrazol-5-yl)-[11'-biphenyl]-4-yl)methyl)-24-dimethyl-58-dihydropyrido[23-d]pyrimidin-7(6H)-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Maillard M P Rossat J Brunner H R et al. Tasosartan enoltasosartan and angiotensin II receptor blockade: The confounding role of protein binding[J]. Journal of Pharmacology & Experimental Therapeutics 2000 295(2):649-654.
molnova catalog
related products
-
Eprosartan Mesylate
Eprosartan is a nonpeptide angiotensin II receptor antagonist.
-
Loxistatin Acid
Loxistatin Acid (E-64C), a derivative of E-64, is an irreversible and membrane-permeant cysteine protease inhibitor.
-
Resorcinolnaphthalei...
Resorcinolnaphthalein is a specific?enhancer of angiotensin-converting enzyme 2 (ACE2) (EC50 value of 19.5 μM). ACE2 activity in a dose-dependent manner enhanced by Resorcinolnaphthalein (100 μM) and XNT (EC50 values of 19.5 μM and 20.1 μM, respectively).